Form 4: Vir Biotechnology Director Restructures Share Ownership for Tax Planning

Norbert W. Bischofberger, a Director at Vir Biotechnology, Inc., transferred 10,667 shares of common stock from direct to indirect ownership for tax planning purposes on June 6, 2025.

Summary

• Norbert W. Bischofberger, a Director of Vir Biotechnology, Inc. (VIR), reported a change in the form of beneficial ownership of common stock.
• On June 6, 2025, Mr. Bischofberger disposed of 10,667 shares of common stock held directly.
• Concurrently, 10,667 shares of common stock were acquired indirectly through Nextquest, LLC, an entity where Mr. Bischofberger is a managing member.
• The transaction was explicitly stated as a transfer without consideration for tax planning purposes, not a sale or purchase for value.
• Following these transactions, Mr. Bischofberger beneficially owns 13,333 shares directly and 10,667 shares indirectly, maintaining a total beneficial ownership of 24,000 shares.

Sentiment

Score: 5

Explanation: Neutral. The transaction is an internal transfer for tax planning and does not reflect a change in the insider's overall beneficial ownership or a market-driven decision, thus having no material impact on company sentiment.

Positives

• The transaction is an internal transfer for tax planning purposes, indicating a strategic management of assets rather than a divestment.
• The reporting person maintains the same overall beneficial ownership of 24,000 shares, demonstrating continued alignment with shareholder interests.

Negatives

• No direct negative implications are apparent from this internal transfer of shares.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic outlook.

Management Comments

• The transaction was a 'Transfer without consideration for tax planning purposes.'

Industry Context

This filing is a routine insider transaction report and does not provide information directly related to broader industry trends or competitive dynamics within the biotechnology sector. It reflects an individual's asset management strategy.

Related Party Transactions

• The indirect beneficial ownership of 10,667 shares is held through Nextquest, LLC, an entity where the Reporting Person, Norbert W. Bischofberger, serves as a managing member.

Stakeholder Impact

• Shareholders: The transaction is an internal restructuring of ownership and does not change the total beneficial ownership of the director, thus having minimal direct impact on other shareholders.
• Employees, Customers, Suppliers, Creditors: No direct impact on these stakeholders as the filing pertains solely to an insider's personal share ownership structure.

Key Dates

Keywords

Vir Biotechnology, VIR, Form 4, Insider Transaction, Beneficial Ownership, Stock Transfer, Tax Planning, Norbert W. Bischofberger, Director